1
Isfordink, Cas J, van Dijk, Marleen, Brakenhoff, Sylvia M, Kracht, Patricia A M, Arends, Joop E, de Knegt, Robert J, van der Valk, Marc, Drenth, Joost P H
Veröffentlicht in: CELINE Study Group , Isfordink , C J , van Dijk , M , Brakenhoff , S M , Kracht , P A M , Arends , J E , de Knegt , R J , van der Valk , M & Drenth , J P H 2022 , ' Hepatitis C Elimination in the Netherlands (CELINE) : How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination ' , European Journal of Internal Medicine , vol. 101 , pp. 93-97 . https://doi.org/10.1016/j.ejim.2022.04.024;
2022
Veröffentlicht in: CELINE Study Group , Isfordink , C J , van Dijk , M , Brakenhoff , S M , Kracht , P A M , Arends , J E , de Knegt , R J , van der Valk , M & Drenth , J P H 2022 , ' Hepatitis C Elimination in the Netherlands (CELINE) : How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination ' , European Journal of Internal Medicine , vol. 101 , pp. 93-97 . https://doi.org/10.1016/j.ejim.2022.04.024;
2022
2
3
4
Cherney, David Z I, Dekkers, Claire C J, Barbour, Sean J, Cattran, Daniel, Abdul Gafor, Abdul Halim, Greasley, Peter J, Laverman, Gozewijn D, Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N, Vervloet, Marc G, Wong, Muh Geot, Gansevoort, Ron T, Heerspink, Hiddo J L
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
5